Danish pharmaceutical giant Novo Nordisk is planning to introduce Ozempic (semaglutide) in India, a once-weekly injectable that was initially approved for type-2 diabetes but is getting recognition as a treatment for obesity
Zydus Lifesciences Ltd. has teamed up with Pinkathon, the largest women's run in India, to announce the 10th edition of the Mumbai Pinkathon on December 21, 2025, at MMRDA Grounds, BKC in Mumbai. The partnership aims to bring key messaging...
Evonik has announced the launch of MaxiPure Polysorbate 80, a highly pure surfactant specifically designed for injectable and biopharmaceutical formulations. Modified to satisfy the strict requirements of current pharmaceuticals development
Sandoz, a global leader in the supply of affordable medicines, announced the US market release of its generic iron sucrose injection, following the US Food and Drug Administration (FDA) approval made recently.
India and Mexico have opened up strategic talks that focus on expanding the Indian pharmaceutical industry's opportunities. The communication is designed to provide better access to cheaper drugs in Mexico
Sanofi has declared a new $625 million multi-year capital commitment to its venture arm, Sanofi Ventures, bringing its total managed assets to over $1.4 billion. This is a considerable enlargement of the evergreen venture fund as it firmly...
Ipca Laboratories has made an accomplishment by signing a Technology Transfer and Joint Development Agreement that is definite with BioSimilar Sciences PR LLC (BSS).
Global Heart Hub and Novartis have put the spotlight on high Lipoprotein(a), or Lp(a), a genetic condition that is often overlooked that entails significant risk for cardiovascular disease such as heart attack and stroke...
Gleneagles Hospital Mumbai, in collaboration with global healthcare technology leader Medtronic, hosted an exclusive medical conclave bringing together more than 100 doctors under one roof.The event highlighted the transformative Hub...
Apollo Hospitals Group is increasing its Genomics services to five additional locations, including Tier-2 cities such as Guwahati, Bhubaneswar, and Indore, to provide more access to genomic testing for the health needs of the country...
.jpg)
, CDSCO.jpg)